Contract Pharma covers BioAgilytix’s recent acquisition of Cambridge Biomedical, a CRO specializing in large molecule bioanalysis based in the biotech hub of Boston, MA.

[EPISODE 25] Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to